CTD Holdings reports second-quarter fiscal 2009 results

NewsGuard 100/100 Score

CTD Holdings, Inc. (OTCBB: CTDH) (FRANKFURT: CDJ) announced today its second quarter results of operations.

Net Operating Loss decreased 36.7% and product sales increased 6.9% to almost $245,000 for the first six months of 2009 compared to the same period in 2008.

"Although profit and loss have not been emphasized by management in the past because the dollar amounts were always small, it's nice to see both going in the right direction. Third quarter sales have gotten off to a great start already," stated Rick Strattan, Chairman/CEO of the company. "We should reduce expenses even more in the third quarter and going forward by eliminating $13,500 per month of non-cash expenses by the elimination of stock for salary to me and George Fails, the new President."

"On the revenue side, the Cyclo™ trials are going well and the list of potential clients for VGP is getting large enough that one or two could well become a reality in the third quarter, or certainly by the fourth quarter," continued Mr. Strattan.

"Finally," Mr. Strattan added, "as a result of the confidence in our new business model, we are going to get more aggressive in the repurchase of our shares on the open market."

SOURCE: CTD Holdings, Inc.

Posted in:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.